 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || T-Plex-200-A0201/204-A0201 / TSCan Therap
Trial initiation date, IO biomarker, Pan tumor, Metastases: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors (clinicaltrials.gov) - Jan 11, 2024
P1, N=100, Recruiting, Sponsor: TScan Therapeutics, Inc.
Initiation date: Nov 2023 --> Feb 2024
- ||| T-Plex-200-A0201/204-A0201 / TSCan Therap
Enrollment open, IO biomarker, Pan tumor, Metastases: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors (clinicaltrials.gov) - Oct 30, 2023
P1, N=100, Recruiting, Sponsor: TScan Therapeutics, Inc.
Initiation date: Nov 2023 --> Feb 2024 Not yet recruiting --> Recruiting
- ||| T-Plex-200-A0201/204-A0201 / TSCan Therap
New P1 trial, IO biomarker, Pan tumor, Metastases: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors (clinicaltrials.gov) - Aug 3, 2023
P1, N=100, Not yet recruiting, Sponsor: TScan Therapeutics, Inc.